1-4 of 4
David A. Price
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Recombinant Modified Vaccinia Ankara Vaccine Encoding Epstein–Barr Virus (EBV) Target Antigens: A Phase I Trial in UK Patients with EBV-Positive Cancer

Graham S. Taylor, Hui Jia, Kevin Harrington, Lip Wai Lee, James Turner, Kristin Ladell, David A. Price, Manjit Tanday, Jen Matthews, Claudia Roberts, Ceri Edwards, Lesley McGuigan, Andrew Hartley, Steve Wilson, Edwin P. Hui, Anthony T. C. Chan, Alan B. Rickinson, Neil M. Steven
Journal: Clinical Cancer Research
Clin Cancer Res (2014) 20 (19): 5009–5022.
https://doi.org/10.1158/1078-0432.CCR-14-1122-T
Published: 30 September 2014
View articletitled, A Recombinant Modified Vaccinia Ankara Vaccine Encoding Epstein–Barr Virus (EBV) Target Antigens: A Phase I Trial in UK Patients with EBV-Positive Cancer
Open the PDF for A Recombinant Modified Vaccinia Ankara Vaccine Encoding Epstein–Barr Virus (EBV) Target Antigens: A Phase I Trial in UK Patients with EBV-Positive Cancer in another window
Includes: Supplementary data
Journal Articles

Profound Inhibition of Antigen-Specific T-Cell Effector Functions by Dasatinib

Ralf Weichsel, Carolin Dix, Linda Wooldridge, Matthew Clement, Angharad Fenton-May, Andrew K. Sewell, Josef Zezula, Elisabeth Greiner, Emma Gostick, David A. Price, Hermann Einsele, Ruth Seggewiss
Journal: Clinical Cancer Research
Clin Cancer Res (2008) 14 (8): 2484–2491.
https://doi.org/10.1158/1078-0432.CCR-07-4393
Published: 15 April 2008
View articletitled, Profound Inhibition of Antigen-Specific T-Cell Effector Functions by Dasatinib
Open the PDF for Profound Inhibition of Antigen-Specific T-Cell Effector Functions by Dasatinib in another window
Includes: Supplementary data
Journal Articles

T-Cell Responses Directed against Multiple HLA-A*0201-Restricted Epitopes Derived from Wilms' Tumor 1 Protein in Patients with Leukemia and Healthy Donors: Identification, Quantification, and Characterization

Katayoun Rezvani, Jason M. Brenchley, David A. Price, Yasemin Kilical, Emma Gostick, Andrew K. Sewell, Jongming Li, Stephan Mielke, Daniel C. Douek, A. John Barrett
Journal: Clinical Cancer Research
Clin Cancer Res (2005) 11 (24): 8799–8807.
https://doi.org/10.1158/1078-0432.CCR-05-1314
Published: 16 December 2005
View articletitled, T-Cell Responses Directed against Multiple HLA-A*0201-Restricted Epitopes Derived from Wilms' Tumor 1 Protein in Patients with Leukemia and Healthy Donors: Identification, Quantification, and Characterization
Open the PDF for T-Cell Responses Directed against Multiple HLA-A*0201-Restricted Epitopes Derived from Wilms' Tumor 1 Protein in Patients with Leukemia and Healthy Donors: Identification, Quantification, and Characterization in another window
Journal Articles

In vitro Induction of Myeloid Leukemia–Specific CD4 and CD8 T Cells by CD40 Ligand – Activated B Cells Gene Modified to Express Primary Granule Proteins

Hiroshi Fujiwara, J. Joseph Melenhorst, Frank El Ouriaghli, Sachiko Kajigaya, Matthias Grube, Giuseppe Sconocchia, Katayoun Rezvani, David A. Price, Nancy F. Hensel, Daniel C. Douek, A. John Barrett
Journal: Clinical Cancer Research
Clin Cancer Res (2005) 11 (12): 4495–4503.
https://doi.org/10.1158/1078-0432.CCR-04-2363
Published: 15 June 2005
View articletitled, In vitro Induction of Myeloid Leukemia–Specific CD4 and CD8 T Cells by CD40 Ligand – Activated B Cells Gene Modified to Express Primary Granule Proteins
Open the PDF for In vitro Induction of Myeloid Leukemia–Specific CD4 and CD8 T Cells by CD40 Ligand – Activated B Cells Gene Modified to Express Primary Granule Proteins in another window